EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Advanced Medical Isotope Corporation (RDGL) had EBIT Margin of -9303.03% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.03M |
|
$-2.91M |
|
$0.03M |
|
$-0.00M |
|
$2.63M |
|
$-2.60M |
|
$-0.31M |
|
$-2.91M |
|
$-2.91M |
|
$-2.91M |
|
$-2.91M |
|
$-2.91M |
|
$-2.91M |
|
$-2.60M |
|
$-2.60M |
|
409.67M |
|
409.67M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$2.23M |
|
-- |
|
-- |
|
$2.23M |
|
$0.09M |
|
-- |
|
-- |
|
$0.09M |
|
$-7.20M |
|
$2.15M |
|
$2.15M |
|
440.87M |
|
| Cash Flow Statement Financials | |
$-1.68M |
|
-- |
|
$2.30M |
|
$1.59M |
|
$2.21M |
|
$0.62M |
|
$1.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
25.91 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.66% |
|
-9303.03% |
|
|
EBIT Margin |
-9303.03% |
-9303.03% |
|
-10396.31% |
|
-10396.31% |
|
$-1.68M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
2.71 |
|
134.63 |
|
40.41% |
|
-135.54% |
|
-130.31% |
|
-135.54% |
|
$0.00 |
|
$-0.00 |
|
$-0.00 |
|